ScholarLens Back to search
2007•Modern hospitalRequires access

A COMPARISON STUDY ON THE EFFICACY AND SAFETY OF ARIPIPRAZOLE AND RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA

Yinglian Cai

Open publisher page 2 citations

Abstract

Objective To investigate the clinical efficacy and side effects of Aripiprazole and Risperidone in the treatment of schizophrenia. Method 100 patients with schizophrenia meeting CCMD-3 criteria were randomly divided into two groups treated with Aripiprazole or Risperidone for 8 weeks respectively. The efficacy was evaluated by PANSS and CGI-SI before and at the ends of 2,4,8 weeks in the treatment, adverse effects by TESS. Result The clinical efficacy in Aripiprazole group was similar to that in Risperidone, without significance(p0.05). Adverse effects in the Aripiprazole group was fewer than that in the Risperidone group,but it was not significant (p0.05). Conclusion Aripiprazole and Risperidone have similar efficacy in the treatment of schizophrenia.

About this research paper

What this paper is about

Objective To investigate the clinical efficacy and side effects of Aripiprazole and Risperidone in the treatment of schizophrenia. Method 100 patients with schizophrenia meeting CCMD-3 criteria were randomly divided into two groups treated with Aripiprazole or Risperidone for 8 weeks respectively. The efficacy was evaluated by PANSS and CGI-SI before and at the ends of 2,4,8 weeks in the treatment, adverse effects by TESS. Result The clinical efficacy in Aripiprazole group was similar to that in Risperidone, without significance(p0.05). Adverse effects in the Aripiprazole group was fewer than that in the Risperidone group,but it was not significant (p0.05). Conclusion Aripiprazole and Risperidone have similar efficacy in the treatment of schizophrenia.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical efficacy and side effects of Aripiprazole and Risperidone in the treatment of schizophrenia. Method 100 patients with schizophrenia meeting CCMD-3 criteria were randomly divided into two groups treated with Aripiprazole or Risperidone for 8 weeks respectively. The efficacy was evaluated by PANSS and CGI-SI before and at the ends of 2,4,8 weeks in the treatment, adverse effects by TESS. Result The clinical efficacy in Aripiprazole group was similar to that in Risperidone, without significance(p0.05). Adverse effects in the Aripiprazole group was fewer than that in the Risperidone group,but it was not significant (p0.05). Conclusion Aripiprazole and Risperidone have similar efficacy in the treatment of schizophrenia.

Key concepts: Aripiprazole, Risperidone, Schizophrenia (object-oriented programming), Clinical efficacy, Medicine, Adverse effect, Side effect (computer science), Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
A COMPARISON STUDY ON THE EFFICACY AND SAFETY OF ARIPIPRAZOLE AND RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA — Research Paper | ScholarLens